BE482003A - - Google Patents
Info
- Publication number
- BE482003A BE482003A BE482003DA BE482003A BE 482003 A BE482003 A BE 482003A BE 482003D A BE482003D A BE 482003DA BE 482003 A BE482003 A BE 482003A
- Authority
- BE
- Belgium
- Prior art keywords
- acid
- amide
- benzilic
- weight
- parts
- Prior art date
Links
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 15
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- UKXSKSHDVLQNKG-UHFFFAOYSA-N benzilic acid Chemical class C=1C=CC=CC=1C(O)(C(=O)O)C1=CC=CC=C1 UKXSKSHDVLQNKG-UHFFFAOYSA-N 0.000 claims description 5
- 150000001408 amides Chemical class 0.000 claims description 3
- 229940087675 benzilic acid Drugs 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- REQXYFLFNBBIRX-UHFFFAOYSA-N 2-hydroxy-2,2-diphenylacetamide Chemical compound C=1C=CC=CC=1C(O)(C(=O)N)C1=CC=CC=C1 REQXYFLFNBBIRX-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DLFVBJFMPXGRIB-UHFFFAOYSA-M ethanimidate Chemical compound CC([O-])=N DLFVBJFMPXGRIB-UHFFFAOYSA-M 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N isopropyl alcohol Natural products CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- OAWAAMJYWXIJGI-UHFFFAOYSA-N CC(NC(C(C1=CC=CC=C1)(C1=CC=CC=C1)OC(C)=O)=O)=O Chemical compound CC(NC(C(C1=CC=CC=C1)(C1=CC=CC=C1)OC(C)=O)=O)=O OAWAAMJYWXIJGI-UHFFFAOYSA-N 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical group CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000002648 merrit Nutrition 0.000 description 1
- 244000087976 merrit Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002917 oxazolidines Chemical class 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE482003A true BE482003A (de) |
Family
ID=128822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE482003D BE482003A (de) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE482003A (de) |
-
0
- BE BE482003D patent/BE482003A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0551230B1 (de) | Cyano-2-Hydroxy-3-Enamid-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel, diese enthaltende pharmazeutische Zusammensetzungen und erhaltene Zwischenprodukte | |
| CA1116635A (fr) | Procede de preparation de nouveaux derives de la benzene propanamine et de leurs sels | |
| CA1312333C (fr) | Sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant | |
| CA1095520A (fr) | Procede de preparation de nouveaux derives de 20,21- dinoreburnamenine | |
| EP0223674A1 (de) | 7-Acyl-benzoxazinone und deren Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen | |
| BE482003A (de) | ||
| EP0183577B1 (de) | Auf das Zentralnervensystem wirksame Thiadiazolderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
| WO1981002295A1 (fr) | Phenoxyisobutyrates de moroxydine et medicaments les contenant | |
| CA1045140A (en) | Ester of n-(8 trifluoromethyl 4- quinolyl)-anthranilate | |
| CA1076583A (fr) | Procede de preparation de nouveaux derives de n-hydroxy thiazole 5-carboxamide | |
| FR2491471A1 (fr) | Benzoxazolinones substituees, leur preparation et leur application en therapeutique | |
| CH407161A (fr) | Procédé de préparation de nouveaux dérivés de l'acétanilide | |
| EP0039294B1 (de) | Bis-(substituierte Phenoxyacetate) von N-Alkyl-dialkanolaminen, Verfahren zu ihrer Bereitung, und diese enthaltende pharmazeutische Zusammensetzungen | |
| EP0057141B1 (de) | Ester von Halogenbiphenylcarboxylaten, deren Herstellungsverfahren und deren Verwendung als Arzneimittel | |
| CH629796A5 (en) | Therapeutically active compounds of 4-(2-thienylmethylamino)benzoic acid | |
| BE493355A (de) | ||
| CH427801A (fr) | Procédé de préparation de dérivés du succinimide | |
| BE504036A (de) | ||
| BE574132A (de) | ||
| BE825890A (fr) | Medicament a base d'un p-alcanoyl-toluene | |
| BE551299A (de) | ||
| BE480069A (de) | ||
| BE597799A (de) | ||
| FR2460945A2 (fr) | Nouveaux derives d'acides 4h 1,3-benzodioxin-2-carboxyliques, un procede pour leur preparation et leur application comme medicaments | |
| BE488998A (de) |